AMAG PHARMACEUTICALS INC - NOTE 3.250% 6/0

CUSIP: 00163UAD8

Q1 2019 13F Holders as of 31 Mar 2019

Type / Class
Debt / NOTE 3.250% 6/0
Market price (% of par)
87.0%
Total 13F principal
$283,231,440
Principal change
-$5,588,066
Total reported market value
$249,512,054
Number of holders
28
Value change
-$3,064,656
Number of buys
10
Number of sells
15

Quarterly Holders Quick Answers

What is CUSIP 00163UAD8?
CUSIP 00163UAD8 identifies 00163UAD8 - AMAG PHARMACEUTICALS INC - NOTE 3.250% 6/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AMAG PHARMACEUTICALS INC - NOTE 3.250% 6/0 as of Q1 2019

As of 31 Mar 2019, AMAG PHARMACEUTICALS INC - NOTE 3.250% 6/0 was held by 28 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $283,231,440 in principal (par value) of the bond. The largest 10 bondholders included TENOR CAPITAL MANAGEMENT Co., L.P., CNH PARTNERS LLC, CITADEL ADVISORS LLC, WOLVERINE ASSET MANAGEMENT LLC, CAMDEN ASSET MANAGEMENT L P /CA, Allianz Asset Management GmbH, STEELHEAD PARTNERS LLC, DEUTSCHE BANK AG\, CALAMOS ADVISORS LLC, and Whitebox Advisors LLC. This page lists 28 institutional bondholders reporting positions for the Q1 2019 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.